Gestational Trophoblastic Disease

Radiologic Clinics of North America

Volumn 51, Issue 6, 2013, Pages 1023-1034

  Shanbhogue, Alampady K P ^a   Lalwani, Neeraj ^b   Menias, Christine O ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Choriocarcinoma; Hydatidiform mole; Magnetic resonance imaging

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; METHOTREXATE; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL HYSTERECTOMY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STAGING; CHORIOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CURETTAGE; FIGO SCORING SYSTEM; FIRST TRIMESTER PREGNANCY; GRAY SCALE ECHOGRAPHY; HUMAN; HYDATIDIFORM MOLE; LIVER METASTASIS; LONG TERM SURVIVAL; LUNG METASTASIS; LYMPH NODE DISSECTION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSVAGINAL ECHOGRAPHY; TROPHOBLASTIC TUMOR; TUMOR INVASION; TUMOR VOLUME;

CHORIOCARCINOMA; HYDATIDIFORM MOLE; MAGNETIC RESONANCE IMAGING;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY; RADIOPHARMACEUTICALS; ULTRASONOGRAPHY;

EID: 84887196817     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2013.07.011     Document Type: Review

References (62)

1. Seckl M.J., Dhillon T., Dancey G., et al. Increased gestational age at evacuation of a complete hydatidiform mole: does it correlate with increased risk of requiring chemotherapy?. JReprod Med 2004, 49:527-530.
2. Seckl M.J., Gillmore R., Foskett M., et al. Routine terminations of pregnancy-should we screen for gestational trophoblastic neoplasia?. Lancet 2004, 364:705-707.
3. Sebire N.J., Foskett M., Fisher R.A., et al. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG 2002, 109:99-102.
4. Semer D.A., Macfee M.S. Gestational trophoblastic disease: epidemiology. Semin Oncol 1995, 22:109-112.
5. Soper J.T., Mutch D.G., Schink J.C. Diagnosis and treatment of gestational trophoblastic disease: ACOG practice bulletin no. 53. Gynecol Oncol 2004, 93:575-585.
6. Bracken M.B. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol 1987, 94:1123-1135.
7. Palmer J.R. Advances in the epidemiology of gestational trophoblastic disease. JReprod Med 1994, 39:155-162.
8. Atrash H.K., Hogue C.J., Grimes D.A. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol 1986, 154:906-909.
9. Goldstein D.P., Berkowitz R.S. Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am 2012, 26:111-131.
10. Smith H.O., Qualls C.R., Prairie B.A., et al. Trends in gestational choriocarcinoma: a 27-year perspective. Obstet Gynecol 2003, 102:978-987.
11. Seckl M.J., Sebire N.J., Berkowitz R.S. Gestational trophoblastic disease. Lancet 2010, 376:717-729.
12. Buckley J.D., Henderson B.E., Morrow C.P., et al. Case-control study of gestational choriocarcinoma. Cancer Res 1988, 48:1004-1010.
13. Altieri A., Franceschi S., Ferlay J., et al. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003, 4:670-678.
14. Fisher R.A., Newlands E.S. Gestational trophoblastic disease. Molecular and genetic studies. JReprod Med 1998, 43:87-97.
15. Pattillo R.A., Sasaki S., Katayama K.P., et al. Genesis of 46,XY hydatidiform mole. Am J Obstet Gynecol 1981, 141:104-105.
16. Lawler S.D., Fisher R.A., Dent J. Aprospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol 1991, 164:1270-1277.
17. Berkowitz R.S., Goldstein D.P. Chorionic tumors. NEngl J Med 1996, 335:1740-1748.
18. Goldstein D.P., Berkowitz R.S. Current management of complete and partial molar pregnancy. JReprod Med 1994, 39:139-146.
19. Berkowitz R.S., Goldstein D.P. Clinical practice. Molar pregnancy. NEngl J Med 2009, 360:1639-1645.
20. Gemer O., Segal S., Kopmar A., et al. The current clinical presentation of complete molar pregnancy. Arch Gynecol Obstet 2000, 264:33-34.
21. Naumoff P., Szulman A.E., Weinstein B., et al. Ultrasonography of partial hydatidiform mole. Radiology 1981, 140:467-470.
22. Fowler D.J., Lindsay I., Seckl M.J., et al. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 2006, 27:56-60.
23. Kirk E., Papageorghiou A.T., Condous G., et al. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole. Ultrasound Obstet Gynecol 2007, 29:70-75.
24. Sebire N.J., Rees H., Paradinas F., et al. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol 2001, 18:662-665.
25. Benson C.B., Genest D.R., Bernstein M.R., et al. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000, 16:188-191.
26. Romero R., Horgan J.G., Kohorn E.I., et al. New criteria for the diagnosis of gestational trophoblastic disease. Obstet Gynecol 1985, 66:553-558.
27. Allen S.D., Lim A.K., Seckl M.J., et al. Radiology of gestational trophoblastic neoplasia. Clin Radiol 2006, 61:301-313.
28. Levine D. Obstetric MRI. JMagn Reson Imaging 2006, 24:1-15.
29. Berkowitz R.S., Im S.S., Bernstein M.R., et al. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. JReprod Med 1998, 43:81-86.
30. Santos-Ramos R., Forney J.P., Schwarz B.E. Sonographic findings and clinical correlations in molar pregnancy. Obstet Gynecol 1980, 56:186-192.
31. Wagner B.J., Woodward P.J., Dickey G.E. From the archives of the AFIP. Gestational trophoblastic disease: radiologic-pathologic correlation. Radiographics 1996, 16:131-148.
32. Baergen R.N., Rutgers J.L., Young R.H., et al. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006, 100:511-520.
33. Sebire N.J., Lindsay I., Fisher R.A., et al. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol 2005, 24:21-29.
34. Kohorn E.I. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. JReprod Med 2002, 47:445-450.
35. FIGO Committee on Gynecologic Oncology Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2009, 105:3-4.
36. Agarwal R., Harding V., Short D., et al. Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia. Br J Cancer 2012, 106:1089-1094.
37. Green C.L., Angtuaco T.L., Shah H.R., et al. Gestational trophoblastic disease: a spectrum of radiologic diagnosis. Radiographics 1996, 16:1371-1384.
38. Barton J.W., McCarthy S.M., Kohorn E.I., et al. Pelvic MR imaging findings in gestational trophoblastic disease, incomplete abortion, and ectopic pregnancy: are they specific?. Radiology 1993, 186:163-168.
39. Nagayama M., Watanabe Y., Okumura A., et al. Fast MR imaging in obstetrics. Radiographics 2002, 22:563-580. [discussion: 580-2].
40. Leyendecker J.R., Gorengaut V., Brown J.J. MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics 2004, 24:1301-1316.
41. Hricak H., Demas B.E., Braga C.A., et al. Gestational trophoblastic neoplasm of the uterus: MR assessment. Radiology 1986, 161:11-16.
42. Sakamoto C., Oikawa K., Kashimura M., et al. Sonographic appearance of placental site trophoblastic tumor. JUltrasound Med 1990, 9:533-535.
43. Sumi Y., Ozaki Y., Shindoh N., et al. Placental site trophoblastic tumor: imaging findings. Radiat Med 1999, 17:427-430.
44. Kumar J., Ilancheran A., Ratnam S.S. Pulmonary metastases in gestational trophoblastic disease: a review of 97 cases. Br J Obstet Gynaecol 1988, 95:70-74.
45. Soper J.T. Identification and management of high-risk gestational trophoblastic disease. Semin Oncol 1995, 22:172-184.
46. Berkowitz R.S., Goldstein D.P. Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu 1981, 11:391-411.
47. May T., Goldstein D.P., Berkowitz R.S. Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract 2011, 2011:806256.
48. Masselli G., Gualdi G. MR imaging of the placenta: what a radiologist should know. Abdom Imaging 2013, 38(3):573-587.
49. Powles T., Savage P., Short D., et al. Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?. Br J Cancer 2006, 94:51-54.
50. Gamer E.I., Garrett A., Goldstein D.P., et al. Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. JReprod Med 2004, 49:411-414.
51. Mutch D.G., Soper J.T., Baker M.E., et al. Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1986, 68:348-352.
52. 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study. Eur J Nucl Med Mol Imaging 2006, 33:156-163.
53. Gerulath A.H., Ehlen T.G., Bessette P., et al. Gestational trophoblastic disease. JObstet Gynaecol Can 2002, 24:434-446.
54. Newlands E.S. Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumours 1997, Chapman and Hall, London.
55. Sebire N.J., Foskett M., Paradinas F.J., et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet 2002, 359:2165-2166.
56. Lurain J.R. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 2011, 204:11-18.
57. Pezeshki M., Hancock B.W., Silcocks P., et al. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol 2004, 95:423-429.
58. van Trommel N.E., Massuger L.F., Verheijen R.H., et al. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol 2005, 99:6-13.
59. Powles T., Savage P.M., Stebbing J., et al. Acomparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer 2007, 96:732-737.
60. Bower M., Newlands E.S., Holden L., et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. JClin Oncol 1997, 15:2636-2643.
61. Crawford R.A., Newlands E., Rustin G.J., et al. Gestational trophoblastic disease with liver metastases: the Charing Cross experience. Br J Obstet Gynaecol 1997, 104:105-109.
62. Woolas R.P., Bower M., Newlands E.S., et al. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol 1998, 105:1032-1035.